SNPSHIGH SIGNALFINANCIAL10-K

SNPS completed its major ANSYS acquisition, transforming into a simulation and analysis leader while experiencing significant integration costs that substantially reduced profitability despite strong revenue growth.

The completed $35B+ ANSYS merger represents a transformational shift for Synopsys, expanding from pure EDA/IP into simulation and analysis solutions, evidenced by the new "S&A" segment language and strategic positioning as an "AI-powered products" enabler. However, the acquisition's integration costs and financing impact are materializing immediately, with net income declining substantially while revenue grew meaningfully, suggesting investors should expect continued margin pressure during the integration period.

Comparing 2025-12-22 vs 2024-12-19View on EDGAR →
FINANCIAL ANALYSIS

The financial profile reflects a major acquisition year, with revenue growing strongly to $5.1B and gross profit expanding modestly to $5.4B, while profitability metrics declined significantly as integration costs and financing expenses weighed on results. The balance sheet shows clear acquisition impacts through substantially higher accounts receivable, increased current liabilities, and reduced cash reserves, while R&D spending increased notably to support the expanded technology portfolio. The overall picture signals successful revenue integration from the ANSYS deal but meaningful near-term margin compression from combining two large technology organizations.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
+61.1%
$934.5M$1.5B

Receivables surged 61.1% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Net Income
P&L
-41.1%
$2.3B$1.3B

Net income declined 41.1% — review whether driven by operations, interest costs, or non-recurring items.

Current Liabilities
Balance Sheet
+40.5%
$2.7B$3.7B

Current liabilities surged 40.5% — significant near-term obligations; verify ability to meet short-term debt.

Capital Expenditure
Cash Flow
+37.6%
$123.2M$169.5M

Capital expenditure jumped 37.6% — major investment cycle underway; assess returns on deployment.

Operating Income
P&L
-32.5%
$1.4B$914.9M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Interest Expense
P&L
-30.6%
$1.7M$1.2M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Cash & Equivalents
Balance Sheet
-25.9%
$3.9B$2.9B

Cash decreased 25.9% — monitor burn rate and upcoming capital needs.

Revenue
P&L
+20.9%
$4.2B$5.1B

Revenue growing 20.9% — solid top-line momentum, watch margins for quality of growth.

R&D Expense
P&L
+19.1%
$2.1B$2.5B

R&D investment increased 19.1% — signals commitment to future product development, though near-term margin impact.

Gross Profit
P&L
+11.2%
$4.9B$5.4B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

LANGUAGE CHANGES
NEW — 2025-12-22
PRIOR — 2024-12-19
ADDED
On December 15, 2025, 191,318,206 shares of Common Stock were outstanding.
This Form 10-K includes, among others, forward-looking statements regarding: our acquisition of ANSYS, Inc.
(the Ansys Merger), and its expected impact; business and market outlook, opportunities, strategies, technological trends, such as artificial intelligence, and initiatives and opportunities, including among other things, our reallocation of resources in our Design IP segment to higher growth opportunities; the potential impact of the uncertain macroeconomic and global economic conditions on our financial results; the impact of current and future U.S.
Following this change, our fiscal quarters end on January 31, April 30, July 31 and October 31 of each year.
(Synopsys, we, our or us) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products.
+7 more — sign up free →
REMOVED
On December 16, 2024, 154,578,449 shares of Common Stock were outstanding.
This Form 10-K includes, among others, forward-looking statements regarding: business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; planned acquisitions and their expected impact, including our pending acquisition of ANSYS, Inc.
(the Ansys Merger); the potential impact of the uncertain macroeconomic environment on our financial results, including, but not limited to, the effects of sustained global inflationary pressures and interest rates, potential economic slowdowns or recessions, supply chain disruptions and geopolitical pressures; the expected impact of U.S.
Fiscal 2023 and 2022 were 52-week years and ended on October 28, 2023 and October 29, 2022, respectively.
Our fiscal quarters will end on January 31, April 30, July 31 and October 31 of each year.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →